FRIDAY, May 23, 2025 (HealthDay News) A federal deadline ending sale of off-brand weight-loss and diabetes medications is now in effect, cutting off access to drugs many patients count on
Below are a few case references that shed light on various angles of the Kailera/GLP-1/IPO story
Christensen MB, Calanna S, Holst JJ, Vilsboll T, Knop FK
Despite barriers, GLP-1 coverage seen as an attractive and desired benefit Most HR decision-makers are open to adding GLP-1 medications to their benefits package 81% feel their employees are interested
Balanced Diet : Antioxidant-rich foods like citrus, berries, and leafy greens work synergistically